Patients receiving a stable oral dosage of carbamazepine were switched to an intravenous ( IV ) carbamazepine formulation solubilized in a cyclodextrin matrix ( at a 70 % dosage conversion ) for either a 15 - or a 30-min infusion every 6 h for up to 7 days and then switched back .